CNS Diseases World Summit
September 12 - 15, 2016 - Boston CA USGTCbio
infogtcbio@gtcbio.com
Phone:16262566405
Fax:16262566405
We are excited to announce the CNS Diseases World Summit, to be held on September 12-15, 2016 in Boston, MA. This meeting provides an interactive learning and relationship-building forum for all players in the CNS field. Colleagues from industry, academia, government agencies, and financing bodies will gather at the interface of research, partnerships, funding, and commercialization to find ways to move forward in a field that has been troubled with clinical failures. The program will provide a comprehensive look at the current state of CNS, from research to commercialization. Above all, this event will provide networking opportunities in an intimate and accessible environment. The CNS Diseases World Summit consists of two, back-to-back conferences: 10th Neurodegenerative Conditions Research & Development Sessions include: I. Neuroinflammation Across CNS Disorders II. Advances in Parkinson’s Disease Research & Therapeutics III. Advances in Genetics and Systems Biology IV. Biomarkers: Translation from Discovery to Clinical V. Novel Therapeutics & Approaches in Alzheimer’s Disease VI. Rare and Orphan CNS Disorders 9th CNS Partnering & Deal-Making Sessions include: I. CNS: Present and Future II. Partnering & Licensing in CNS Panels include: I. Is Now the Time for Neurodegeneration R&D? II. What Sells Big Pharma in CNS III. Partnering with Patient Groups to Advance Research IV. Regulatory Considerations for Orphan Drug Products V. CNS Perspectives: Venture Capital and Public Markets A summit pass will get you access to both conferences. We invite you to join us as we connect, build relationships, and seek new ways forward into the future of CNS research and development. We hope to see you there!